Atlas company financials

GLOBUS MEDICAL INC

Standardized 16-year financial series for GLOBUS MEDICAL INC, built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0001237831FY2010 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$2.9B

Adjusted EBITDA

—

Net result

$537.9M

Net financial debt

—

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$769M

TTM revenue

$2.7B

TTM free cash flow

—

Latest quarter net result

$119M

Quarterly coverage: 44 periods · latest quarter FY2025-Q3 · TTM revenue growth 43.2%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · globus-medical-inc-fy2010 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-03-05 · Retrieved: 2026-04-26T11:46:31.008080+00:00
SEC EDGAR companyfacts
us-gaap:CashAndCashEquivalentsAtCarryingValue · us gaap companyfacts · comparative · globus-medical-inc-fy2010 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-06-13 · Retrieved: 2026-04-26T11:46:31.008080+00:00
SEC EDGAR companyfacts
primary · globus-medical-inc-fy2013 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-03-14 · Retrieved: 2026-04-26T11:46:31.008080+00:00
SEC EDGAR companyfacts
primary · globus-medical-inc-fy2014 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2015-02-26 · Retrieved: 2026-04-26T11:46:31.008080+00:00
SEC EDGAR companyfacts
primary · globus-medical-inc-fy2015 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2016-02-29 · Retrieved: 2026-04-26T11:46:31.008080+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2010	288M	—	88M	54M	71M	-12M	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing current assets · missing current liabilities · missing interest expense · missing inventory · missing net financial debt · missing total assets
FY2011	331M	—	97M	61M	76M	-22M	—	comparative annual fact carried from later 10k · missing adjusted ebitda · missing interest expense · missing net financial debt
FY2012	386M	—	115M	74M	77M	-25M	—	missing adjusted ebitda · missing interest expense · missing net financial debt
FY2013	434M	—	102M	69M	93M	-24M	—	missing adjusted ebitda · missing interest expense · missing net financial debt
FY2014	474M	—	138M	92M	79M	-25M	—	missing adjusted ebitda · missing interest expense · missing net financial debt
FY2015	545M	—	172M	113M	122M	-51M	—	missing adjusted ebitda · missing interest expense · missing net financial debt
FY2016	564M	—	154M	104M	172M	-41M	—	missing adjusted ebitda · missing interest expense · missing net financial debt
FY2017	7M	—	162M	107M	160M	-51M	—	missing adjusted ebitda · missing interest expense · missing net financial debt
FY2018	713M	—	169M	156M	182M

Filing provenance